Present Genomic, based in Hong Kong, is a health Next Generation Sequencing (NGS) services provider. Our mission is to help patients to better understand their health condition by revealing the secret codes of their DNA. We deliver cancers, prenatal and cardiovascular diseases genetic testing services using NGS technology techniques, that are safe, accurate, fast and simple. What are the benefits of genetic testing ? It allows the patient to make an early detection of genetic variation and to predict the disease risks by screening the genes before even any disease exists. Early treatment could be applied, preventing patients from suffering of the disease.
| Website | http://www.presentgene.com/ |
| Revenue | $6.6 million |
| Employees | 5 (0 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+7 more
(view full list)
|
| Industry | Health, Wellness and Fitness, Biotechnology, Pharmaceuticals, Healthcare |
| Keywords | Next Generation Sequencing, Ngs Services, Dna Sequencing, Genetic Testing, Health Diagnostics, Personalized Medicine, Cancer Diagnostics, Prenatal Testing, Genome Sequencing, Genetic Screening, Molecular Diagnostics, Clinical Genomics, Dna Analysis, Genetic Analysis, Healthcare Technology, Medical Diagnostics, Precision Medicine, Health Technology, Biotechnology, Genomics Services |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, QIAGEN, Myriad Genetics, GeneDx, Oxford Nanopore Technologies, Fulgent Genetics, BGI Genomics, PacBio +41 more (view full list) |
Looking for a particular Present Genomic employee's phone or email?
Present Genomic Questions
The Present Genomic annual revenue was $6.6 million in 2026.
Present Genomic is based in Hong Kong, Central and Western.
Related Companies
